tiprankstipranks
Capricor Therapeutics, Inc. (CAPR)
NASDAQ:CAPR
Want to see CAPR full AI Analyst Report?

Compare Capricor Therapeutics (CAPR) vs. Competitors

1,299 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Capricor Therapeutics
$34.70
$1.69B
-15.02
196.93%
8 Buy
0 Hold
0 Sell
Strong Buy
Galectin Therapeutics
$5.71
$169.25M
-6.31
103.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alector
$2.57
$238.70M
-1.91
52.11%
3 Buy
3 Hold
2 Sell
Hold
4D Molecular Therapeutics
$10.49
$468.92M
-4.19
167.12%
7 Buy
2 Hold
0 Sell
Strong Buy
Humacyte
$0.71
$284.18M
-2.64
-53.07%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CAPR
Capricor Therapeutics
29.96
19.75
193.44%
GALT
Galectin Therapeutics
2.52
1.23
95.35%
ALEC
Alector
2.16
0.78
56.52%
IMAB
FDMT
4D Molecular Therapeutics
9.91
6.16
164.27%
HUMA
Humacyte
1.30
-1.32
-50.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts